bms ccr2 22 (MedChemExpress)
Structured Review

Bms Ccr2 22, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bms+ccr2+22/BMS+CCR2+22/pmc13179327-331-42-43
Average 94 stars, based on 2 article reviews
Images
1) Product Images from "Aging promotes a RAGE-dependent increase in breast cancer metastasis"
Article Title: Aging promotes a RAGE-dependent increase in breast cancer metastasis
Journal: Communications Biology
doi: 10.1038/s42003-026-10022-4
Figure Legend Snippet: Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the CCR2 inhibitor BMS-CCR2-22 (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.
Techniques Used: Migration
Related Articles
Inhibition:Article Title: Aging promotes a RAGE-dependent increase in breast cancer metastasis Article Snippet: .. Where indicated, inhibitors were added directly to both upper and lower chambers at the time of plating: 1 μM TTP488 (MedChemExpress) for RAGE inhibition, 25 μM Paquinimod (Cayman Chemicals) for S100A8/9 blockade, 10 μM BX471 (MedChemExpress) for CCR1 inhibition, or 10 μM |
![Effect of DSF on monocyte migration in vitro. ( A ) Schematic diagram of the Boyden chamber-based monocyte chemotaxis assay toward lung cell culture supernatant (LCCS). Monocytes in input cells and migrated cells were quantified by flow cytometry, and the migration efficiency (number of monocytes in migrated cells/number of monocytes in input cells [%]) was calculated. ( B ) Migration efficiency of monocytes after <t>CCR2</t> inhibitor (BMS CCR2 22) pretreatment. n = 3 or 4 per group. ( C ) Concentrations of 13 chemokines (CXCL1, CXCL5, CXCL9, CXCL10, CXCL13, CCL2, CCL3, CCL4, CCL5, CCL11, CCL17, CCL20, and CCL22) as migration factors in the supernatant of lung tissue-derived cells of C57BL/6J mice after 72 h of culture. ( D ) Migration efficiency of monocytes pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). n = 3 per group. ( E ) Percentage of viable bone marrow cells pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). The percentage of viable cells not treated with inhibitors was used as the reference (100%). n = 3 per group. * P < 0.05, ** P < 0.01 (Tukey’s test).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_4646/pmc11464646/pmc11464646__41598_2024_71770_Fig5_HTML.jpg)